Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Kelun Pharmaceutical
Hunan Sheng, Chinakelun.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hunan Kelun Pharmaceutical Co., Ltd. is an active pharmaceutical manufacturing subsidiary under Sichuan Kelun Pharmaceutical. It focuses on small molecule drugs and chemical pharmaceuticals with several approved products in China including antibiotics, immunomodulators, contrast agents, and treatments for neurological disorders. The broader Kelun Group has significant R&D capabilities in innovative biologics and antibody-drug conjugates through its other subsidiaries.
- Therapeutic areas
- Metabolic DisordersImmunologyOtherOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculeChemical drugsContrast agentPeptideMonoclonal antibodyAntibody-drug conjugate
- Industry
- Biotech
Beyond the preview
Go deeper on Hunan Kelun Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hunan Kelun Pharmaceutical.